Clinical Trial Update: Evaluation of Two Doses of Nitric Oxide (NO) Given Intermittently Via Inhalation to Subjects With Bronchiolitis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intermittent inhaled nitric oxide at two doses in subjects with bronchiolitis acute has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchiolitis Acute

Drugs mentioned

• Nitric Oxide (NO) inhalation (nitric oxide)

Snippet

Sponsor: Beyond Air Inc. | Conditions: Bronchiolitis Acute | Phase 2 | Status: COMPLETED